Macquarie Group’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-250,200
| Closed | -$13K | – | 1812 |
|
|
2022
Q4 | $13K | Hold |
250,200
| – | – | ﹤0.01% | 1712 |
|
|
2022
Q3 | $298K | Hold |
250,200
| – | – | ﹤0.01% | 1574 |
|
|
2022
Q2 | $450K | Sell |
250,200
-17,862
| -7% | -$32.1K | ﹤0.01% | 1601 |
|
|
2022
Q1 | $541 | Hold |
268,062
| – | – | ﹤0.01% | 1634 |
|
|
2021
Q4 | $726K | Hold |
268,062
| – | – | ﹤0.01% | 1609 |
|
|
2021
Q3 | $1.2M | Buy |
268,062
+17,009
| +7% | +$75.9K | ﹤0.01% | 1541 |
|
|
2021
Q2 | $1.46M | Hold |
251,053
| – | – | ﹤0.01% | 1513 |
|
|
2021
Q1 | $1.76M | Sell |
251,053
-405
| -0.2% | -$2.84K | ﹤0.01% | 1244 |
|
|
2020
Q4 | $1.21M | Hold |
251,458
| – | – | ﹤0.01% | 1261 |
|
|
2020
Q3 | $1.47M | Hold |
251,458
| – | – | ﹤0.01% | 1135 |
|
|
2020
Q2 | $1.7M | Buy |
251,458
+151,258
| +151% | +$1.02M | ﹤0.01% | 1058 |
|
|
2020
Q1 | $637K | Hold |
100,200
| – | – | ﹤0.01% | 1207 |
|
|
2019
Q4 | $1.05M | Hold |
100,200
| – | – | ﹤0.01% | 1228 |
|
|
2019
Q3 | $394K | Hold |
100,200
| – | – | ﹤0.01% | 1415 |
|
|
2019
Q2 | $1.49M | Hold |
100,200
| – | – | ﹤0.01% | 1104 |
|
|
2019
Q1 | $2.49M | Hold |
100,200
| – | – | ﹤0.01% | 946 |
|
|
2018
Q4 | $1.8M | Sell |
100,200
-778,330
| -89% | -$14M | ﹤0.01% | 989 |
|
|
2018
Q3 | $25.8M | Buy |
878,530
+187,071
| +27% | +$5.49M | 0.04% | 416 |
|
|
2018
Q2 | $31.4M | Buy |
691,459
+75,589
| +12% | +$3.44M | 0.05% | 374 |
|
|
2018
Q1 | $32.5M | Buy |
615,870
+95,699
| +18% | +$5.05M | 0.06% | 346 |
|
|
2017
Q4 | $35.4M | Sell |
520,171
-6,709
| -1% | -$456K | 0.06% | 317 |
|
|
2017
Q3 | $43.4M | Buy |
526,880
+189,211
| +56% | +$15.6M | 0.08% | 239 |
|
|
2017
Q2 | $31.6M | Buy |
+337,669
| New | +$31.6M | 0.06% | 321 |
|